Identification of angiotensin converting enzyme inhibitory and antioxidant peptides in a whey protein concentrate hydrolysate produced at semi-pilot scale

International Journal of Food Science and Technology

Volumn 52, Issue 8, 2017, Pages 1751-1759

  O'Keeffe, Martina B ^a   Conesa, Celia ^a   FitzGerald, Richard J ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Angiotensin converting enzyme inhibition; antioxidant; ESI MS MS; food protein hydrolysate; mass spectrometry; oxygen radical absorbance capacity assay; peptide identification; whey protein concentrate

Indexed keywords

ANTIOXIDANTS; ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INTEGRATED CIRCUITS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDES; PROTEINS; SCALES (WEIGHING INSTRUMENTS); ULTRAFILTRATION;

ANGIOTENSIN-CONVERTING ENZYME; ESI-MS/MS; FOOD PROTEINS; OXYGEN RADICAL ABSORBANCE CAPACITIES; PEPTIDE IDENTIFICATION; WHEY PROTEIN CONCENTRATE;

ENZYME INHIBITION;

EID: 85019270258     PISSN: 09505423     EISSN: 13652621     Source Type: Journal    
DOI: 10.1111/ijfs.13448     Document Type: Article

References (45)

1. Adler-Nissen, J. (1986). A review of food hydrolysis specific areas. In: Enzymatic Hydrolysis of Food Proteins (edited by J. Adler-Nissen). Pp. 57–109. New York: Elsevier Applied Science Publishers.
2. Chang, O.K., Seol, K.H., Jeong, S.G. et al. (2013). Casein hydrolysis by Bifidobacterium longum KACC91563 and antioxidant activities of peptides derived there from. Journal of Dairy Science, 96, 5544–5555.
3. Chen, C., Pearson, A.M. & Gray, J.I. (1992). Effects of synthetic antioxidants (BHA, BHT and PG) on the mutagenicity of IQ-like compounds. Food Chemistry, 43, 177–183.
4. Contreras, M.D., Hernandez-Ledesma, B., Amigo, L., Martin-Alvarez, P.J. & Recio, I. (2011a). Production of antioxidant hydrolyzates from a whey protein concentrate with thermolysin: optimization by response surface methodology. LWT-Food Science and Technology, 44, 9–15.
5. Contreras, M.d.M, Sevilla, M.A, Monroy-Ruiz, J. et al. (2011b). Food-grade production of an antihypertensive casein hydrolysate and resistance of active peptides to drying and storage. International Dairy Journal, 21, 470–476.
6. Duffy, S., Gokce, N., Holbrook, M. et al. (1999). Treatment of hypertension with ascorbic acid. The Lancet, 354, 2048–2049.
7. Fatehi-Hassanabad, Z., Chan, C.B. & Furman, B.L. (2010). Reactive oxygen species and endothelial function in diabetes. European Journal of Pharmacology, 636, 8–17.
8. FitzGerald, R.J., Murray, B.A. & Walsh, D.J. (2004). Hypotensive peptides from milk proteins. Journal of Nutrition, 134, 980S–988S.
9. Foltz, M., Meynen, E.E., Bianco, V., van Platerink, C., Koning, T.M.M.G. & Kloek, J. (2007). Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. Journal of Nutrition, 137, 953–958.
10. Hernandez-Ledesma, B., Davalos, A., Bartolome, B. & Amigo, L. (2005). Preparation of antioxidant enzymatic hydrolysates from α-lactalbumin and β-lactoglobulin. Identification of active peptides by HPLC-MS/MS. Journal of Agricultural and Food Chemistry, 53, 588–593.
11. Hernández-Ledesma, B., Amigo, L., Recio, I. & Bartolomé, B. (2007a). ACE-inhibitory and radical-scavenging activity of peptides derived from -lactoglobulin f(19−25). Interactions with ascorbic acid. Journal of Agricultural and Food Chemistry, 55, 3392–3397.
12. Hernández-Ledesma, B., Quirós, A., Amigo, L. & Recio, I. (2007b). Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin. International Dairy Journal, 17, 42–49.
13. Juraschek, S.P., Guallar, E., Appel, L.J. & Miller, E.R. (2012). Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition, 95, 1079–1088.
14. Kleekayai, T., Harnedy, P.A., O'Keeffe, M.B. et al. (2015). Extraction of antioxidant and ACE inhibitory peptides from Thai traditional fermented shrimp pastes. Food Chemistry, 176, 441–447.
15. Li, Y.-W. & Li, B. (2013). Characterization of structure–antioxidant activity relationship of peptides in free radical systems using QSAR models: key sequence positions and their amino acid properties. Journal of Theoretical Biology, 318, 29–43.
16. López-Expósito, I., Quirós, A., Amigo, L. & Recio, I. (2007). Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides. Le Lait, 87, 241–249.
17. Mine, Y., Li-Chan, E.C.Y. & Jiang, B. (2010). Biologically active food proteins and peptides in health: an overview. In: Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals (edited by Y. Mine, E. Li-Chan & B. Jiang). Pp. 3–11. Oxford: Wiley-Blackwell.
18. Minkiewicz, P., Dziuba, J., Iwaniak, A., Dziuba, M. & Darewicz, M. (2008). BIOPEP database and other programs for processing bioactive peptide sequences. Journal of AOAC International, 91, 965–980.
19. Nongonierma, A.B., Gaudel, C., Murray, B.A. et al. (2013). Insulinotropic properties of whey protein hydrolysates and impact of peptide fractionation on insulinotropic response. International Dairy Journal, 32, 163–168.
20. Nongonierma, A.B., O'Keeffe, M.B. & FitzGerald, R.J. (2016). Milk protein hydrolysates and bioactive peptides. In: Advanced Dairy Chemistry (edited by P.L.H. McSweeney & J.A. O'Mahony). Pp. 417–482. New York: Springer.
21. Norris, R. & FitzGerald, R.J. (2013). Antihypertensive Peptides from Food Proteins. In: Bioactive Food Peptides in Health and Disease (edited by B. Hernandez-Ledesma & C.C. Hsieh). Pp. 45–72. Rijeka, Croatia: InTech.
22. Norris, R., Casey, F., FitzGerald, R.J., Shields, D. & Mooney, C. (2012). Predictive modelling of angiotensin converting enzyme inhibitory dipeptides. Food Chemistry, 133, 1349–1354.
23. Norris, R., Poyarkov, A., O'Keeffe, M.B. & FitzGerald, R.J. (2014). Characterisation of the hydrolytic specificity of Aspergillus niger derived prolyl endoproteinase on bovine β-casein and determination of ACE inhibitory activity. Food Chemistry, 156, 29–36.
24. Norris, R., O'Keeffe, M.B., Poyarkov, A. & FitzGerald, R.J. (2015). Peptide identification and angiotensin converting enzyme (ACE) inhibitory activity in prolyl endoproteinase digests of bovine αs-casein. Food Chemistry, 188, 210–217.
25. O'Keeffe, M.B. & FitzGerald, R.J. (2014). Antioxidant effects of enzymatic hydrolysates of whey protein concentrate on cultured human endothelial cells. International Dairy Journal, 36, 128–135.
26. O'Keeffe, M.B. & FitzGerald, R.J. (2015). Identification of short peptide sequences in complex milk protein hydrolysates. Food Chemistry, 184, 140–146.
27. O'Loughlin, I.B., Murray, B.A., FitzGerald, R.J., Brodkorb, A. & Kelly, P.M. (2014). Pilot-scale production of hydrolysates with altered bio-functionalities based on thermally-denatured whey protein isolate. International Dairy Journal, 34, 146–152.
28. Pihlanto, A. (2006). Antioxidative peptides derived from milk proteins. International Dairy Journal, 16, 1306–1314.
29. Pihlanto, A., Akkanen, S. & Korhonen, H.J. (2008). ACE-inhibitory and antioxidant properties of potato (Solanum tuberosum). Food Chemistry, 109, 104–112.
30. Power, O., Jakeman, P. & FitzGerald, R.J. (2013). Antioxidative peptides: enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides. Amino Acids, 44, 797–820.
31. Power, O., Fernández, A., Norris, R., Riera, F.A. & FitzGerald, R.J. (2014). Selective enrichment of bioactive properties during ultrafiltration of a tryptic digest of β-lactoglobulin. Journal of Functional Foods, 9, 38–47.
32. Power-Grant, O., McCormack, W.G., Ramia De Cap, M., Amigo-Benavent, M., FitzGerald, R.J. & Jakeman, P. (2016). Evaluation of the antioxidant capacity of a milk protein matrix in vitro and in vivo in women aged 50–70 years. International Journal of Food Sciences and Nutrition, 67, 325–334.
33. Ralph, S.J., Rodríguez-Enríquez, S., Neuzil, J., Saavedra, E. & Moreno-Sánchez, R. (2010). The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapy. Molecular Aspects of Medicine, 31, 145–170.
34. Rival, S.G., Boeriu, C.G. & Wichers, H.J. (2001). Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. Journal of Agricultural and Food Chemistry, 49, 295–302.
35. Rivera, L., Morón, R., Zarzuelo, A. & Galisteo, M. (2009). Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochemical Pharmacology, 77, 1053–1063.
36. Spellman, D., Kenny, P., O'Cuinn, G. & FitzGerald, R.J. (2005). Aggregation properties of whey protein hydrolysates generated with Bacillus licheniformis proteinase activities. Journal of Agricultural and Food Chemistry, 53, 1258–1265.
37. Suetsuna, K. & Chen, J.-R. (2001). Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnology, 3, 305–309.
38. Tavares, T., del Mar Contreras, M., Amorim, M., Pintado, M., Recio, I. & Malcata, F.X. (2011). Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes. Peptides, 32, 1013–1019.
39. Tavares, T.G., Amorim, M., Gomes, D., Pintado, M.E., Pereira, C.D. & Malcata, F.X. (2012). Manufacture of bioactive peptide-rich concentrates from Whey: characterization of pilot process. Journal of Food Engineering, 110, 547–552.
40. Teh, S.-S., Bekhit, A.E.-D.A., Carne, A. & Birch, J. (2016). Antioxidant and ACE-inhibitory activities of hemp (Cannabis sativa L.) protein hydrolysates produced by the proteases AFP, HT, Pro-G, actinidin and zingibain. Food Chemistry, 203, 199–206.
41. Touyz, R.M. & Schiffrin, E.L. (2004). Reactive oxygen species in vascular biology: implications in hypertension. Histochemistry and Cell Biology, 122, 339–352.
42. WHO (2013). Global action plan for the prevention and control of NCDs 2013-2020. URL:www.who.int/nmh/events/ncd-action-plan/en/
43. WHO (2015). Cardiovascular Diseases (CVDs). Factsheet No. 317. Updated January 2015. URL: www.who.int/mediacentre/factsheets/fs317/en/
44. Wu, J., Aluko, R.E. & Nakai, S. (2006a). Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues. QSAR & Combinatorial Science, 25, 873–880.
45. Wu, J., Aluko, R.E. & Nakai, S. (2006b). Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure−activity relationship study of di- and tripeptides. Journal of Agricultural and Food Chemistry, 54, 732–738.